# Cancer Prevention and Control

> **NIH NIH P30** · EMORY UNIVERSITY · 2022 · $57,188

## Abstract

PROJECT SUMMARY/ABSTRACT
The Cancer Prevention and Control (CPC) Program coordinates and promotes all of the cancer prevention
and control-related research activities within Winship Cancer Institute of Emory University. Through program
planning and evaluation, CPC leads innovative research that aims to generate the knowledge needed to
reduce the cancer burden in Georgia and beyond. Research within the program is organized around four
scientific themes: (1) Cancer Epidemiology, which aims to identify risk factors, including individual biological
and behavioral factors, community and policy factors, and environmental exposures in an effort to inform
targeted interventions and strategies to reduce cancer risk in Georgia; (2) Interventions, which focuses on
chemoprevention trials, individual behavioral interventions, and policy and systems-level changes with the
ultimate goal of broad-scale implementation of effective strategies; (3) Cancer Survivorship, which focuses
on treatment-related early effects, including patient-reported outcomes, biobehavioral changes in the brain,
and late effects such as cardiovascular diseases, all of which substantially affect the quality-of-life of cancer
survivors; and (4) Quality of Cancer Care, which aims to conduct population-based research that describes,
interprets, and predicts the impact of health care interventions and other factors on quality of cancer care and
outcomes. Under the leadership of Timothy Lash, DSc, MPH (leader) and Andrew Miller, MD (co-leader),
the CPC Program includes 45 core members representing 15 different departments within the School of
Medicine, Rollins School of Public Health, and Nell Hodgson Woodruff School of Nursing at Emory University.
Between 2012 and present this highly collaborative group of researchers published 803 cancer-relevant
scientific articles. Of these, 175 (22%) were intra- and 122 (15%) were inter-programmatic collaborations;
365 (45%) represented a collaboration with another cancer center or other academic organization. As of
March 31, 2016, CPC held $11.7 million in annual total cancer-relevant research funding, of which
approximately $5.8M (50%) was awarded directly from the NCI. The CPC Program has substantially and
directly influenced efforts to reduce the cancer burden in Georgia and beyond, and through strategic planning
has a vision for building on this foundation to expanded impact in the next project period.

## Key facts

- **NIH application ID:** 10595769
- **Project number:** 3P30CA138292-13S3
- **Recipient organization:** EMORY UNIVERSITY
- **Principal Investigator:** Timothy L. Lash
- **Activity code:** P30 (R01, R21, SBIR, etc.)
- **Funding institute:** NIH
- **Fiscal year:** 2022
- **Award amount:** $57,188
- **Award type:** 3
- **Project period:** 2009-04-07 → 2023-03-31

## Primary source

NIH RePORTER: https://reporter.nih.gov/project-details/10595769

## Citation

> US National Institutes of Health, RePORTER application 10595769, Cancer Prevention and Control (3P30CA138292-13S3). Retrieved via AI Analytics 2026-05-24 from https://api.ai-analytics.org/grant/nih/10595769. Licensed CC0.

---

*[NIH grants dataset](/datasets/nih-grants) · CC0 1.0*